ACST · Acasti Pharma Inc

-

-

Please sign in to comment on ACST

1 Comment

Admin
3 years, 7 months ago

Acasti Pharma Inc is currently in a long term uptrend where the price is trading 14.2% above its 200 day moving average.

From a valuation standpoint, the stock is 50.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 661.5.

Acasti Pharma Inc's total revenue rose by inf% to $81K since the same quarter in the previous year.

Its net income has increased by 73.3% to $-3M since the same quarter in the previous year.

Finally, its free cash flow grew by 55.4% to $-4M since the same quarter in the previous year.

Based on the above factors, Acasti Pharma Inc gets an overall score of 5/5.












© PyInvesting 2024

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy